Skip to search formSkip to main contentSkip to account menu

Fezakinumab

Known as: ILV-094, Immunoglobulin G1, Anti-(Human Interleukin 22) (Human Monoclonal Heavy Chain), Disulfide with Human Monoclonal Lambda-Chain, Dimer, Immunoglobulin G1, Anti-(Human/Macaca irus/Rattus/Mus musculus Interleukin 22) (Human Monoclonal Heavy Chain), Disulfide with Human Monoclonal Lambda-Chain, Dimer 
A human monoclonal antibody directed against interleukin-22 (IL-22) with anti-inflammatory activity. Fezakinumab binds to IL-22 and prevents the… 
National Institutes of Health

Related topics

Related topics

1 relation
antigen binding

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Is Fezakinumab, an anti-IL22 antibody, a putative novel therapy for a subset of severe asthma?
Review
2016
Review
2016
Wild Life: The Institution of Nature by Irus Braverman (review)
in Wild Life, Braverman explores concepts of in situ and ex situ conservation and the apparent dichotomy between them. Braverman… 
2008
2008
Treatment of Cytomegalov irus-associated IgA Nephropathy by Deflazacort and Intrav enous Immunoglobulin
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)